Published August 28, 2020
| Version v1
Figure
Open
Figure 2 from: Ilieva V, Kondeva-Burdina M, Georgieva T (2020) In vitro analysis of the activity of human monoamine oxidase type B (hMAOB), treated with the cyanotoxin anatoxin-a: supposed factor of neurodegenerative diseases. Pharmacia 67(2): 111-114. https://doi.org/10.3897/pharmacia.67.e50806
- 1. Medical University of Sofia, Sofia, Bulgaria
- 2. National Center of Public Health and Analyses, Sofia, Bulgaria
Description
Figure 2 Results from hMAOB activity, treated with anatoxin-a. * P < 0.05; ** P < 0.01; *** P < 0.001 vs control (pure hMAOB).
Files
big_444264.jpg
Files
(82.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:975ed0fc7c1cff55e717bd383e8b446c
|
82.6 kB | Preview Download |
Additional details
Related works
- Is part of
- Journal article: 10.3897/pharmacia.67.e50806 (DOI)